A research delegation led by Dai Minmin, Deputy Secretary of the Party Committee and President of Shanghai State-owned Investment Corporation (Shanghai SDIC), recently visited Matwings Technology for a special on-site research visit. Li Xin, Vice President of Shanghai SDIC, and core business team members joined the symposium, hosted by Hong Liang, Founder and Chief Scientist of Matwings Technology, along with the company's executive leadership team.
Dai Minmin (President of Shanghai SDIC) and the delegation in discussion with the Matwings Technology team
The two sides held in-depth exchanges around core topics including real-world application of artificial general intelligence (AGI) in the life sciences, co-construction of the biomanufacturing industrial ecosystem, translation of cutting-edge research achievements, and deep coordination between industrial capital. Responsible persons from the Fund Management Department of Shanghai SDIC, SDIC Futeng Capital, SDIC Future Capital, SDIC Pioneer Capital, and Shanghai Sci-Tech Innovation Group participated in the visit.
01 Powered by AI: Building a full-stack protein innovation platform
At the start of the visit, Hong Liang extended a warm welcome to Dai Minmin and the delegation, and provided a detailed overview of Matwings Technology's development history, core technology system construction, product R&D progress, and overall industrial layout.
Hong Liang presenting Matwings Technology's core technology system to the visiting delegation
Hong noted that as a local Shanghai-grown Specialized, Refined, Differentiated, and Innovative (SRDI) benchmark enterprise, Matwings Technology focuses deeply on the intersection of general artificial intelligence and life sciences. Powered by its self-developed protein foundation model as the core engine, the company has built research agents and automated experimental equipment, launching the dialogue-driven protein R&D agent MatwingsVenus™ (Xiaowu™). The platform delivers end-to-end intelligent R&D solutions covering literature and patent research, protein molecular design, small-scale experimental validation, pilot-scale process optimization, all the way to scaled commercial production, and has already achieved commercial breakthroughs across multiple vertical sectors.
Hong stated that Matwings Technology will continue to focus on core cutting-edge technology breakthroughs, continuously improve its industrial ecosystem layout, deeply integrate into the overall development of Shanghai's biopharmaceutical and artificial intelligence industries, and support Shanghai in building a global hub for biopharmaceutical innovation.
02 Anchoring on the new AI4S paradigm: Empowering benchmark enterprises to accelerate industrial implementation
Dai Minmin, Deputy Secretary of the Party Committee and President of Shanghai SDIC, highly recognized Matwings Technology's technological breakthroughs and industrialization achievements in the AI for Science (AI4S) field. He noted that AI4S should not only transform research paradigms, but also drive industrial upgrading. Shanghai SDIC is firmly focused on cross-disciplinary innovation directions in the new era of AI, adhering to strategic layout, ecosystem building, and systematic enablement, to fully support a cohort of outstanding AI4S enterprises in strengthening their technical foundations, improving innovation models, and accelerating industrial application. He expressed hope for further strengthened cooperation with Matwings Technology, to jointly promote large-scale application and industrial landing of new AI technologies and paradigms across protein structure and function design, innovative pharmaceuticals, new materials, circular economy, and synthetic biology, and to develop Shanghai-based model demonstrations for AI4S.
Going forward, Matwings Technology will continue to focus on iterative upgrades of its universal protein foundation model and deep adaptation for vertical scenarios, continuously expanding the technical boundaries of AI for Science. Taking this research exchange as an opportunity, the company will actively partner with Shanghai SDIC and ecosystem partners to accelerate the translation of cutting-edge scientific and technological achievements from laboratory to production line, and deliver more benchmark industrialization cases in key fields including innovative drugs and synthetic biology. Rooted in Shanghai and serving national strategic priorities, Matwings Technology will use AI as a lever to unlock the full potential of biomanufacturing, and contribute core strength to Shanghai's development as a global innovation hub for biopharmaceuticals and artificial intelligence.
MatwingsVenus™ (Xiaowu™) is continuously undergoing iterative upgrades. Scan the QR code below or click "Read Original" to experience conversational protein research instantly.
